These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16749527)

  • 1. Tamoxifen citrate loaded solid lipid nanoparticles (SLN): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation.
    Reddy LH; Vivek K; Bakshi N; Murthy RS
    Pharm Dev Technol; 2006; 11(2):167-77. PubMed ID: 16749527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro cytotoxicity and bioavailability of solid lipid nanoparticles containing tamoxifen citrate.
    Hashem FM; Nasr M; Khairy A
    Pharm Dev Technol; 2014 Nov; 19(7):824-32. PubMed ID: 24032414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-lipoic acid-stearylamine conjugate-based solid lipid nanoparticles for tamoxifen delivery: formulation, optimization, in-vivo pharmacokinetic and hepatotoxicity study.
    Dhaundiyal A; Jena SK; Samal SK; Sonvane B; Chand M; Sangamwar AT
    J Pharm Pharmacol; 2016 Dec; 68(12):1535-1550. PubMed ID: 27709612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
    Vivek K; Reddy H; Murthy RS
    AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
    Shete H; Patravale V
    Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen citrate-loaded poly(d,l) lactic acid nanoparticles: Evaluation for their anticancer activity in vitro and in vivo.
    Ravikumara NR; Bharadwaj M; Madhusudhan B
    J Biomater Appl; 2016 Nov; 31(5):755-772. PubMed ID: 27664187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self nanoprecipitating preconcentrate of tamoxifen citrate for enhanced bioavailability.
    Kapse SV; Gaikwad RV; Samad A; Devarajan PV
    Int J Pharm; 2012 Jun; 429(1-2):104-12. PubMed ID: 22414426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen citrate loaded ethosomes for transdermal drug delivery system: preparation and characterization.
    Sarwa KK; Suresh PK; Debnath M; Ahmad MZ
    Curr Drug Deliv; 2013 Aug; 10(4):466-76. PubMed ID: 23656399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles.
    Mazumdar S; Italiya KS; Sharma S; Chitkara D; Mittal A
    Int J Pharm; 2018 May; 543(1-2):96-106. PubMed ID: 29578081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.
    Kalam MA; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K
    J Drug Target; 2010 Apr; 18(3):191-204. PubMed ID: 19839712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.
    Rawat MK; Jain A; Singh S
    J Pharm Sci; 2011 Jun; 100(6):2366-78. PubMed ID: 21491449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization.
    Varia JK; Dodiya SS; Sawant KK
    Curr Drug Deliv; 2008 Jan; 5(1):64-9. PubMed ID: 18220553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approach for overcoming the stability challenges of lipid-based excipients. Part 3: Application of polyglycerol esters of fatty acids for the next generation of solid lipid nanoparticles.
    Corzo C; Meindl C; Lochmann D; Reyer S; Salar-Behzadi S
    Eur J Pharm Biopharm; 2020 Jul; 152():44-55. PubMed ID: 32387704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical characterization of sildenafil-loaded solid lipid nanoparticle dispersions (SLN) for pulmonary application.
    Paranjpe M; Finke JH; Richter C; Gothsch T; Kwade A; Büttgenbach S; Müller-Goymann CC
    Int J Pharm; 2014 Dec; 476(1-2):41-9. PubMed ID: 25261709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
    Aji Alex MR; Chacko AJ; Jose S; Souto EB
    Eur J Pharm Sci; 2011 Jan; 42(1-2):11-8. PubMed ID: 20971188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity.
    Memisoglu-Bilensoy E; Vural I; Bochot A; Renoir JM; Duchene D; Hincal AA
    J Control Release; 2005 Jun; 104(3):489-96. PubMed ID: 15911048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats.
    Rawat MK; Jain A; Singh S
    J Pharm Sci; 2011 Jun; 100(6):2406-17. PubMed ID: 21491451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: Characterization, pharmacokinetic and deposition study.
    Ahmad I; Pandit J; Sultana Y; Mishra AK; Hazari PP; Aqil M
    Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():959-970. PubMed ID: 30948132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of linalool-loaded solid lipid nanoparticles using experimental factorial design and long-term stability studies with a new centrifugal sedimentation method.
    Pereira I; Zielińska A; Ferreira NR; Silva AM; Souto EB
    Int J Pharm; 2018 Oct; 549(1-2):261-270. PubMed ID: 30075252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.